This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Daniel Heitmann
Introduction
Daniel Heitmann is a notable inventor based in Zürich, Switzerland. He is recognized for his significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work has the potential to advance therapeutic applications in various medical fields.
Latest Patents
Heitmann holds a patent titled "Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies." This invention relates to bivalent bispecific monoclonal antibodies (bbmAb) or variants thereof. It outlines methods for manufacturing such antibodies by co-expressing modified Fc-mutated derivatives of two different monoclonal antibodies in mammalian cell lines. He has 1 patent to his name.
Career Highlights
Daniel Heitmann is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Heitmann collaborates with talented professionals in his field, including Michael Otto Bardroff and Tina Buch. These collaborations enhance the research and development process, fostering innovation and creativity in their projects.
Conclusion
Daniel Heitmann's work in the field of bispecific antibodies exemplifies the impact of innovative thinking in biotechnology. His contributions are paving the way for new therapeutic solutions that could benefit many patients in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile